REFERENCES
- Jemal A, Tiwari RC, Murray T, , et al. American Cancer Society. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8–29. [PUBMED], [INFOTRIEVE], [CSA]
- Ward E, Jemal A, Cokkinides V, , et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78–93. [PUBMED], [INFOTRIEVE], [CSA]
- Carroll PR, Lee KL, Kantoff PW. Cancer of the prostate In: DeVita VT Jr., Hellman S, Rosenberg SA, eds. Cancer, Principles and Practice of Oncology, ed 6. Philadelphia: Lippincott-Willams & Wilkins;; 2001:1418–1479.
- Taper HS, de Gerlache J, Lans M. Roberfriod M. Non-toxic potentiation of cancer chemotherapy by combined C and K3 vitamin pretreatment. Int J Cancer 1987;40:575–579. [PUBMED], [INFOTRIEVE]
- Noto V, Taper HS, Yi-Hau J, Janssens J, Bonte J, De Loecker W. Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4 -naphtoquinone (vitamin K3) treatment on human tumor cell growth in vitro. Cancer 1989;63:901–906. [PUBMED], [INFOTRIEVE]
- De Loecker W, Janssens J, Bonte J, Taper HS. Effects of sodium ascorbate (vitamin C) and 2-methyl-1, 4-naphtoquinone (vitamin K3) treatment on human tumor cell growth in vitro, II: synergism with combined chemotherapy action. Anticancer Res. 1993;13:103–106. [PUBMED], [INFOTRIEVE]
- Taper HS, Keyeux A, Roberfroid M. Potentiation of radiotherapy by nontoxic pretreatment with combined vitamin C and K3 in mice bearing solid, transplantable tumor. Anticancer Res. 1996;16:499–504. [PUBMED], [INFOTRIEVE], [CSA]
- Gilloteaux J, Jamison JM, Vijayalaksmi M, Giammar D, Summers JL. SEM and TEM aspects of synergistic antitumor activity of vitamin C–vitamin K3 combinations against human prostatic carcinoma cells. Scanning Microsc Int. 1995;9:159–173. [CSA]
- Venugopal M, Jamison JM, Gilloteaux J, , et al. Synergistic antitumor reactivity of vitamins C and K3 against human prostate carcinoma cell lines. Cell Biol Int. 1996;20:787–797. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Venugopal M, Jamison JM, Gilloteaux J, , et al. Synergistic antitumor activity of vitamin C and K3 on human urologic tumor cell lines. Life Sci. 1996;59:1389–1400. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Jamison JM, Gilloteaux J, Venugopal M, Koch JA, Shah R, Summers JL. Flow cytometric and ultrastructural aspects of the synergistic antitumor activity of vitamin C–vitamin K3 combinations against human prostate carcinoma cells. Tissue Cell. 1996;28:687–701. [PUBMED], [INFOTRIEVE], [CSA]
- Gilloteaux J, Jamison JM, Arnold D, , et al. Cancer cell necrosis by autoschizis: synergism of antitumor activity of vitamin C:vitamin K3 on human bladder carcinoma T24 cells. Scanning. 1998;20:564–575. [PUBMED], [INFOTRIEVE], [CSA]
- Gilloteaux J, Jamison JM, Arnold D, Summers JL. Autoschizis: another cell death for cancer cells induced by oxidative stress. In:Motta PM, Machiarelli G, Nottola SA, eds. Advances in Microanatomy of Cells and Tissues, Roma, in Ital J Anat Embryol. 2001;106 (suppl 1):79–91.
- Gilloteaux J, Jamison JM, Arnold D, Taper HS, Summers JL. Ultrastructural aspects of autoschizis: a new cancer cell death induced by the synergistic action of ascorbate/menadione on human bladder carcinoma cells. Ultrastruct Pathol. 2001;25:183–192. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gilloteaux J, Jamison JM, Arnold D, Jarjoura D, Von Greuningen V, Summers JL. Autoschizis of human ovarian carcinoma cells: scanning electron and light microscopy of a new cell death induced by sodium ascorbate:menadione treatment. Scanning. 2003;25:137–149. [PUBMED], [INFOTRIEVE], [CSA]
- Gilloteaux J, Jamison JM., Arnold D, Taper HS, von Greunigen VE, Summers JL Microscopic aspects of autoschizic cell death in human ovarian carcinoma (2774) cells following vitamin C, vitamin K3 or vitamin C:K3 treatment. Microsc Microanal. 2003;9:311–329. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Jamison JM, Gilloteaux J, Nassiri MR, Venugopal M, Neal DR, Summers JL. Cell cycle arrest and autoschizis in a human bladder carcinoma cell line following vitamin C and vitamin K3 treatment. Biochem Pharmacol. 2004;67:337–351. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Calderon PB, Cadrobbi J, Marques C, , et al. Potential therapeutic application of the association of vitamins C and K3 in cancer treatment. Curr Med Chem. 2002;9:2271–2285. [PUBMED], [INFOTRIEVE]
- Verrax J, Carobbi J, Delvaux M, , et al. The association of vitamins C and K3 kills cancer cells mainly by autoschizis, a novel form of cell death: basis for their potential use as coadjuvants in anticancer therapy. Eur J Med Chem. 2003;38:451–457. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Verrax J, Cadrobbi J, Marques C, , et al. Ascorbate potentiates the cytotoxicity of menadione leading to an oxidative stress that kills cancer cells by a non-apoptotic caspase-3 independent form of cell death. Apoptosis. 2004;9:223–235. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Taper HS, Jamison JM, Gilloteaux J, Gwin CA, Gordon T, Summers JL. In vivo reactivation of DNases in implanted human prostate tumors after administration of a vitamin C/K3 combination. J Histochem Cytochem. 2001;49:109–119. [PUBMED], [INFOTRIEVE], [CSA]
- Taper HS, Jamison JM, Gilloteaux J, Summers JL, Calderon PB. Inhibition of the development of metastases by dietary vitamin C: K3 combination. Life Sci. 2004;75:955–967. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Jamison JM, Gilloteaux J, Taper HS, , et al. The in vitro and in vivo antitumor activity of vitamin C:K3 combinations against prostate cancer. In: Lucas JL, ed. Prostate Cancer. Hauppauge, NY: Nova Science; 2004; 423–471.
- Jamison JM, Gilloteaux J, Taper HS, Summers JL. Evaluation of the in vitro and in vivo antitumor activities of vitamin C and vitamin K3 combinations against human prostate cancer. J Nutr. 2001;131:158S–160S. [PUBMED], [INFOTRIEVE]
- Jamison JM, Gilloteaux J, Taper HS, Calderon PB, Summers JL. Autoschizis: a novel cell death. Biochem Pharmacol. 2002;63:1773–1783. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gingrich JR, Barrios RJ, Morton RA, , et al. Metastatic prostate cancer in a transgenic mouse. Cancer Res. 1996;56:4096–4102. [PUBMED], [INFOTRIEVE]
- Gingrich JR, Greenberg NM. A transgenic mouse prostate cancer model. Toxicol Pathol. 1996;24:502–504. [PUBMED], [INFOTRIEVE], [CSA]
- Foster BA, Gingrich JR, Kwon ED, Madias C, Greenberg NM. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Cancer Res. 1997;25:3325–3330.
- Karnovsky MJ. The ultrastructural basis of capillary permeability studied with peroxidase as a tracer. J Cell Biol. 1967;35:213–236. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Song SK, Shimada N, Anderson PJ. Orthogonal diameters in the analysis of muscle fibers and for. Nature. 1963;200:1220–1221. [PUBMED], [INFOTRIEVE]
- Brandes D, Kirchem D, Scott WW. Ultrastructure of the human prostate: normal and neoplastic. Lab Invest. 1964;13:1541–1560. [PUBMED], [INFOTRIEVE]
- Mao P, Nkao K, Angrist A. Human prostatic carcinoma: an electron microscope study. Cancer Res. 1966;26:955–973. [PUBMED], [INFOTRIEVE]
- Kirchheim D, Bacon RL. Ultrastructural studies of carcinoma of the human prostate gland. Invest Urol. 1969;6:611–630. [PUBMED], [INFOTRIEVE]
- Sinha AA, Blackard CE. Ultrastructure of prostatic benign hyperplasia and carcinoma. Urology. 1973;11:114–120. [CROSSREF]
- Burchardt P. Ultrastrukturelle Untersuchungen an Prostatacarcinomzellen. Urologe. 1980;A19:379–384.
- Bostwick DG, Pacelli A, Lopez-Beltran A. Ultrastructure of prostatic intraepithelial neoplasia. The Prostate. 1997;33:32–37. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sahlén GE, Egevad L, Ahlander A, Norlén BJ, Ronquist G, Nilsson BO. Ultrastructure of the secretion of prostasomes from benign and malignant epithelial cells in the prostate. The Prostate. 2002;53:192–199. [CROSSREF]
- Schatten H, Wiedemer Am, Taylor M, , et al. Centrosome–centriole abnormalities are markers for abnormal cell divisions and cancer in the transgenic adenocarcinoma mouse prostate (TRAMP) model. Biol Cell. 2000;92:331–340. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kemp TI, Kim Js, Crist SA, Griffith TS. Induction of necrotic tumor cell death by TRAIL/apo-2L. Apoptosis. 2003;8:587–599. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bram S, Froussard P, Guichard M, , et al. Vitamin C preferential toxicity for malignant melanoma cells. Nature. 1980;284:629–631. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Park CH, Amare M, Savin MA, Hoogstraten B. Growth suppression for malignant leukemic cells in vitro by L-ascorbic acid. Cancer Res. 1980;40:1062–1065. [PUBMED], [INFOTRIEVE]
- Prasad KN, Sinha PK, Ramanujam M, Sakamoto A. Sodium ascorbate potentiates the growth inhibitory effect of certain agents on neuroblastoma cells in culture. Proc Natl Acad Sci USA. 1979;76:829–832. [PUBMED], [INFOTRIEVE]
- Liotti FS, Menghini AR, Guerrieri P, Talsea V, Bodo M. Effects of ascorbic acid and dehydroascorbic acid on the multiplication of tumor ascite cells in vitro. J Cancer Res Clin Oncol. 1984;108:230–232. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Reynolds CP, Perez-Polo JR. Ascorbic acid enhances the cytotoxic effect of 6-hydroxydopamine for human neuroblastoma cell lines. Neurosci Lett. 1981;23:151–155. [CROSSREF]
- Koch CJ, Biaglow JE. Toxicity, radiation sensitivity modification and metabolic effects of dehydroxyascorbate and ascorbate in mammalian cells. J Cell Physiol. 1978;94:299–306. [PUBMED], [INFOTRIEVE], [CROSSREF]
- De Laurenzi V, Melino G, Savini I, Annicchiarico-Petruzelli M, Finazzi-Agro À, Avigliano L. Cell death by oxidative stress and ascorbic acid regeneration in human neurectodermal cell lines. Eur J Cancer 1995;31:463–466. [CROSSREF]
- Daruwala R, Song J, Koh WS, Rumsey SC, Levine M. Cloning and functional characterization of the human sodium-dependent vitamin C transporters hSVCT1 and hSVCT2. FEBS Lett. 1999;460:480–484. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wang Y, MacKenzie B, Tsukaguchi H, Weremowicz S, Morton CC, Hediger MA. Human vitamin C (L-ascorbic acid) transporter SVCT1. Biochem Biophys Res Commun. 2000;267:488–494. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Liang W-J, Johnson D, Jarvis Sm. Vitamin C transport systems of mammalian cells. Mol Membr Biol. 2001;18:87–95. [PUBMED], [INFOTRIEVE], [CSA]
- Chandler JD, Williams ED, Slavin JL, Best JD, Rogers S. Expression and localization of GLUT1 and GLUT12 in prostate carcinoma. Cancer 2003;97:2035–2042. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yamafuji K, Nakamura Y, Omura H, Soeda T, Gyotoku K. Antitumor potency of ascorbic acid, dehydroascorbic or 2,3-diketogulonic acid and their action on deoxyribonucleic acid. Z. Krebsforsch. Onkol. Cancer Res. Clin. Oncol. 1971;76:1–7.
- Morgan AR, Cone RL, Elgert TM. The mechanism of DNA strand breakage by vitamin C and superoxide and the protective roles of catalase and superoxide dismutase. Nucleic Acids Res. 1976;3:1139–1149. [PUBMED], [INFOTRIEVE]
- Lupulescu A. Vitamin C inhibits DNA, RNA and protein synthesis in epithelial neoplastic cells. Int J Vitam Nutr Res. 1991;61:125–129. [PUBMED], [INFOTRIEVE]
- Leung PY, Miyashita K, Young M, Tsao CS. Cytologic effect of ascorbate and its derivatives on cultured malignant and nonmalignant cell lines. Anticancer Res. 1993;13:475–480. [PUBMED], [INFOTRIEVE]
- Maramag C, Menon M, Blaji KC, Reddy PG, Laxmanan S. Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability, and DNA synthesis. Prostate 1997;32:188–195. [PUBMED], [INFOTRIEVE]
- Taper HS. Reversibility of acid and alkaline deoxyribonuclease deficiency in malignant tumor cells. J Histochem Cytochem. 1980;29:1053–1060.
- Prasad KN, Edwards-Prasad J, Sakamoto A. Vitamin K3 (Menadione) inhibits the growth of mammalian tumor cells in culture. Life Sci. 1979;29:1387–1392.
- Nutter LM, Cheng AL, Hung HL, Hsieh RK, Ngo EO, Liu TW. Menadione: spectrum of anticancer therapy and effects on nucleoside metabolism in human neoplastic cell lines. Biochem Pharmacol. 1991;41:1283–1292. [PUBMED], [INFOTRIEVE], [CSA]
- Ngo EO, Sun TP, Chang JY, , et al. Menadione-induced DNA damage in a human tumor cell line. Biochem Pharmacol. 1991;42:1961–1968. [PUBMED], [INFOTRIEVE], [CSA]
- Wu FY, Chang NT, Chen WJ, Juan CC. Vitamin K3-induced cell cycle arrest and apoptotic cell death are accompanied by altered expression of c-fos and c-myc in nasopharyngeal carcinoma cells. Oncogene 1993;8:2237–2244. [PUBMED], [INFOTRIEVE], [CSA]
- Wu FY, Liao WC, Chang HM. Comparison of antitumor activity of vitamins K1, K2 and K3 on human tumor cells by two (MTT and SRB) cell viability assays. Life Sci. 1993;52:1797–1804. [PUBMED], [INFOTRIEVE]
- Cohen GM, Stubberfield CR. Pyridine nucleotide changes in hepatocytes exposed to quinones. Free Radic Res Commun. 1990;8:355–363. [PUBMED], [INFOTRIEVE]
- Bellomo G, Mirabelli F, Vairetti M, Iosi F, Mallorni W. Cytoskeleton as a target in menadione-induced oxidative stress in cultured mammalian cells: biochemical and immunocytochemical features. J Cell Physiol. 1990;143:118–128. [PUBMED], [INFOTRIEVE]
- Malorni W, Iosi F, Mirabelli F, Belomo G. Cytoskeleton as a target in menadione-induced oxidative stress in cultured mammalian cells: alterations underlying surface blebs formation. Chem Biol Interact. 1991;80:217–235. [PUBMED], [INFOTRIEVE], [CSA]
- Jarabak R, Jarabak J. Effect of ascorbate on the DT-diaphorase-mediated redox cycling of 2-methyl-1, 4-naphthoquinone. Arch Biochem Biophys. 1995;318:418–423. [PUBMED], [INFOTRIEVE], [CSA]
- Benade L, Howard T, Burk D. Synergistic killing of Ehrlich ascites carcinoma cells by ascorbate and 3-amino-2,3,4-triazole. Oncology. 1969;23:33–43. [PUBMED], [INFOTRIEVE]
- Pethig R, Gascoyne PR, McLaughlin JA, Szent-Gyorgyi A. Ascobate–quinone interactions: electrochemical, free radical, and cytotoxic properties. Proc Natl Acad Sci USA 1983;80:129–132. [PUBMED], [INFOTRIEVE]
- Kastendieck H, Altenähr E, Burchardt P. Zur Ultrastruktur des behandelten Prostatacarcinoms: Befunde nach kombinierter Hormon- und Strahlentherapie. Virchows Arch A. 1975;366:287–304.
- Gilloteaux J, Jamison JM, Lorimer HE, , et al. Autoschizis: a new form of cell death for human ovarian carcinoma cells following ascorbate: menadionbe treatment. Nuclear and DNA degradation. Tissue & Cell. 2004;36:197–210. [CSA]
- Feder N, Wolf MK. Studies on nucleic acid metachromasy, II: metachromatic and orthochromatic staining by toluidine blue of nucleic acids in tissue sections. J Cell Biol. 1965;27:327–336. [PUBMED], [INFOTRIEVE]